Teleost Biopharmaceutical is moving its headquarters from Boulder, Colorado to Tucson, Arizona to partner with the original UA inventors of the technology.

A technology developed at the University of Arizona offers an innovative way to grow vascularized human tissue – an advance that has applications in testing potential drug therapies and the development of treatments for cardiovascular disease.

Headquartered in Flagstaff, SenesTech is a platform bio-technology and research company that is commercializing an innovative technology for managing animal populations by targeting their ability to reproduce as opposed to lethally poisoning populations.

The University of Arizona has announced an agreement with Xtronaut Enterprises, Inc. to bring STEM-related educational and public outreach products related to the OSIRIS-REx asteroid sample return mission to classrooms everywhere.

Tech Parks Arizona is pleased to announce that the Arizona Center for Innovation (AzCI) is receiving a $50,000 grant from the US Small Business Administration.

Tech Parks Arizona announced two new tenants at the UA Tech Park, Thompson-Wimmer and Cleveland Electric Laboratories.

Fiscal year 2014 marked the best year to date for technology commercialization at the University of Arizona, the UA's Tech Launch Arizona office reported Thursday.

The UA's Intellectual Property Policy plays a key role in the commercialization process, and the campus community is being invited to weigh in on proposed revisions to that policy.